VEGF-related protein isolated from Vipera palestinae venom, promotes angiogenesis

References

• Annex BH, Simons M. Growth factor-induced therapeutic angiogenesis in the heart: Protein therapy. Cardiovasc Res 2005; 65: 649–655
   PubMed Web of Science ®Google Scholar
• Calvete JJ, Moreno-Murciano MP, Theakston RDG, Kisiel DG, Marcinkiewicz C. Snake venom disintegrins: Novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J 2003; 372: 725–734
   PubMed Web of Science ®Google Scholar
• Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardiovasc Res 2005; 65: 639–648
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653–660
   PubMed Web of Science ®Google Scholar
• Chen YL, Tsai IH, Hong TM, Tsai SH. Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF. Thromb Haemost 2005; 93: 331–338
   PubMed Web of Science ®Google Scholar
• Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851–858
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis. Annu Rev Med 2005; 57: 1–18
   Web of Science ®Google Scholar
• Fuh G, Li B, Crowley C, Cunnibgham B, Wells JA. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem 1998; 273: 11197–11204
   PubMed Web of Science ®Google Scholar
• Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001; 276: 3222–3230
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. Neuropilin-2 is a receptor for the vascular endothelail growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem 2000; 275: 18040–18045
   PubMed Web of Science ®Google Scholar
• Gsami A, Bourcier C, Aloui Z, Srairi N, Marchetti S, Gimond S, Wedge SR, Hennequin L, Pouyssegur J. Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. J Biol Chem 2002; 277: 29992–29998
   PubMed Web of Science ®Google Scholar
• Juárez P, Sanz L, Calvete JJ. Snake venomics: Characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics 2004; 4: 327–338
   PubMed Web of Science ®Google Scholar
• Kisiel DG, Calvete JJ, Katzhendler J, Fertala A, Lazarovici P, Marcinkiewicz C. Structural determinants of the selectivity of KTS-disintegrins for the a1b1 integrin. FEBS Lett 2004; 577: 465–469
   PubMed Web of Science ®Google Scholar
• Komori Y, Nikai T, Taniguchi T, Masuda K, Sugihara H. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper). Biochemistry 1999; 38: 11796–11803
   PubMed Web of Science ®Google Scholar
• Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 1996; 93: 1988–1992
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachiane G, Kuang WJ, Goddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, Kalluri R. Identification of the anti-angiogenic site within vascular basement-derived tumstatin. J Biol Chem 2001; 276: 15240–15248
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C, Calvete JJ, Marcinkiewicz MM, Raida M, Lobb RR, Senadhi VK, Huang Z, Niewiarowski S. EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. J Biol Chem 1999; 274: 12468–12473
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C, Lobb RR, Marcinkiewicz MM, Daniel JL, Smith JB, Dangelmaier C, Weinreb PH, Beacham DA, Niewiarowski S. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the a2b1 integrin. Biochemistry 2000; 39: 9859–9867
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz C, Wainreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, Lobb RR. Obtustatin, a potent inhibitor of a1b1 integrin in vitro and angiogenesis in vivo. Cancer Res 2003; 63: 2020–2023
   PubMed Web of Science ®Google Scholar
• Muller YA, Li B, Christinger HW, Wells JA, Cunningham BC, de Vos MA. Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA 1997; 94: 7192–7197
   PubMed Web of Science ®Google Scholar
• Parsons-Wingerter P, Lwai B, Yang MC, Elliot KE, Milaninia A, Redlitz A, Clark JI, Sage H. A novel assay of angiogenesis in the quail chorioallantoic membrane: Stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res 1998; 55: 201–214
   PubMed Web of Science ®Google Scholar
• Quinn TP, Peters KG, deVries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively express in vascular endothelium. Proc Natl Acad Sci USA 1993; 90: 7533–7537
   PubMed Web of Science ®Google Scholar
• Semenza GL. Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 2000; 106: 809–812
   PubMed Web of Science ®Google Scholar
• Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumoral cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735–745
   PubMed Web of Science ®Google Scholar
• Sun L, Tran N, Tang F, App H, Hirth P, McMahon G, Tang C. Synthesis and biological evaluations of 3-substituted indolin-3-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem 1998; 41: 2588–2603
   PubMed Web of Science ®Google Scholar
• Suto K, Yamazaki Y, Morita T, Mizuno H. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: Insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem 2005; 280: 2126–2131
   PubMed Web of Science ®Google Scholar
• Takahashi H, Hattori S, Iwamatsu A, Takizawa H, Shibuya M. A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J Biol Chem 2004; 279: 46304–46314
   PubMed Web of Science ®Google Scholar
• Tokunaga Y, Yamazaki Y, Morita T. Specific distribution of VEGF-F in Viperinae snake venoms: Isolation and characterization of a VEGF-F from the venom of Daboia russelli siamensis. Arch Biochem Biophys 2005; 439: 241–247
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 2006; 10: 515–527
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Takani K, Atoda H, Morita. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem 2003; 278: 51985–51988
   PubMed Web of Science ®Google Scholar
• de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991
   PubMed Web of Science ®Google Scholar